Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults

Attention Deficit Disorder With Hyperactivity Clinical Trial

Official title:

Treatment of Meta-Cognitive Deficits in Adults With ADHD

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00278473
• Other study ID #: R34MH071721
• Secondary ID: DATR A2-AIR
• Status: Active, not recruiting
• Phase: N/A
• First received: January 13, 2006
• Last updated: December 30, 2008
• Start date: May 2005
• Est. completion date: December 2008

Study information

• Verified date: November 2008
• Source: National Institute of Mental Health (NIMH)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

This study will determine the effectiveness of group cognitive-behavioral therapy as compared to a problem-solving social support group in treating problems of time management, organization, and planning in adults with attention deficit hyperactivity disorder (ADHD).

Description:

ADHD is a chronic neurobiological condition that affects people of all ages, genders, and races. Symptoms of ADHD may include, but are not limited to, the following: poor attention span; physical restlessness or hyperactivity; excessive impulsivity; chronic procrastination; frequently losing things; poor organization, planning, and time management skills; and excessive forgetfulness. Not every person with ADHD exhibits all of these symptoms, and the severity of the disorder can range from mild to severe. While there is no cure for ADHD, the condition can be managed with an accurate diagnosis and proper treatment. Left untreated, individuals with ADHD may experience significant impairment in social, emotional, occupational, and academic functioning. Stimulant and non-stimulant medications are usually effective in alleviating symptoms of ADHD in adults. However, some research suggests that medications may not effectively treat self-management functioning problems and that as many as one-third of adults with ADHD have inadequate responses to medication treatment. Additional research on the benefits of psychosocial treatments for ADHD in adults is needed. This study will determine the effectiveness of group cognitive-behavioral therapy as compared to a problem-solving social support group in treating problems of time management, organization, and planning in adults with ADHD.

Individuals interested in participating in this study will first undergo an assessment of their eligibility for inclusion in the study. The assessment will last approximately 6 hours, but can be broken up into as many as 4 separate visits. Eligible participants will be randomly assigned to either receive group cognitive-behavioral therapy or join a problem-solving social support group. Both groups will meet once a week for 12 weeks. Each session will last roughly 2 hours and will focus on building time management, organizational, and planning skills. Time management, planning, and organizational skill levels will be assessed at the treatment mid-point, immediately following the intervention, and at 3 and 6 months following the treatment. Self-esteem and symptoms of depression and anxiety will also be measured at these visits.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 84
• Est. completion date: December 2008
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Suspected of having or have been diagnosed with ADHD

• May potentially benefit from the ADHD group treatment

Exclusion Criteria:

• Any overt cognitive disability (e.g., Alzheimer's disease, mental retardation)

• Deemed not to potentially benefit from the proposed ADHD group treatment

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Attention Deficit Disorder With Hyperactivity
• Hyperkinesis

Intervention

Behavioral:
• Cognitive Behavioral Group Treatment
Cognitive behavioral therapy focuses on changing patterns of thinking and behavior. Each group consists of 6 to 8 members and sessions are led by a psychologist.
• Social Support Problem-Solving Group Treatment
Social support problem-solving focuses on general support, problem solving, and information sharing. Each group consists of 6 to 8 members and sessions are led by a psychologist.

Locations

Country	Name	City	State
United States	The Mount Sinai Medical Center	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time management, organization and planning skills		Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment	No
Primary	ADHD symptoms		Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment	No
Secondary	Depression symptoms		Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment	No
Secondary	Anxiety		Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment	No
Secondary	Self-esteem		Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment	No

External Links

•   Click here for the Mount Sinai Attention Deficit Hyperactivity Disorder Center website